Vyant Bio Inc expected to post a loss of 61 cents a share - Earnings Preview

Vyant Bio

24/03/2023 22:21

* Vyant Bio Inc  VYNT.OQ   VYNT.O  is expected to show a
rise in
quarterly revenue when it reports  results on March 27
(estimated). 
    * The Cherry Hill New Jersey-based  company is expected to
report 
a 100.9% decrease in revenue to $24 thousand from $-2.53 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Vyant Bio Inc is
for a
loss of 61 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Vyant Bio
Inc is
$5​, above​ its last closing price of $0.65. ​​​

This summary was machine generated March 24 at 22:21 GMT.  All
figures in US dollars  unless otherwise stated